Department of Internal Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Abstract
Massive pulmonary thromboembolism (PTE) has an increased risk of mortality. Thrombolytic therapy is the accepted treatment. Reteplase, a variant of tissue plasminogen activator, has been used in acute myocardial infarction with acceptable safety and efficacy, but studies in massive PTE are rare. In this study we report five cases of successful treatment of massive PTE with reteplase.
Ghobadi,H. , Amirajam,Z. and Habibzadeh,A. (2018). Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series. TANAFFOS (Respiration), 17(1), 53-56.
MLA
Ghobadi,H. , , Amirajam,Z. , and Habibzadeh,A. . "Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series", TANAFFOS (Respiration), 17, 1, 2018, 53-56.
HARVARD
Ghobadi H., Amirajam Z., Habibzadeh A. (2018). 'Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series', TANAFFOS (Respiration), 17(1), pp. 53-56.
CHICAGO
H. Ghobadi, Z. Amirajam and A. Habibzadeh, "Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series," TANAFFOS (Respiration), 17 1 (2018): 53-56,
VANCOUVER
Ghobadi H., Amirajam Z., Habibzadeh A. Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series. TANAFFOS (Respiration), 2018; 17(1): 53-56.
